Interventions for treating oral mucositis for patients with cancer receiving treatment.
暂无分享,去创建一个
S. Furness | T. Khalid | Helen V Worthington | J. E. Clarkson | Martin McCabe | Stefan Meyer | Tasneem Khalid | J. Clarkson
[1] C. Lindsell,et al. Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain: Design and Rationale of a Randomized Controlled Trial , 2020, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[2] C. Haritha,et al. Oral morphine gargles: A cost effective approach for pain relief in patients with chemoradiation induced acute oral mucositis in head and neck cancers. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] T. Kaneko,et al. Preventive Effect of Rebamipide Gargle on Chemoradiotherpy-Induced Oral Mucositis in Patients with Oral Cancer: a Pilot Study , 2011, Journal of oral & maxillofacial research.
[4] K. Mizuta,et al. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer , 2010, International journal of cancer.
[5] Chong Zhao,et al. A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] A. Gillenwater,et al. Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer , 2010, Annals of Internal Medicine.
[7] M. Sanz,et al. Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse. , 2010, Medicina oral, patologia oral y cirugia bucal.
[8] A. Glenny,et al. A Systematic Review of Oral Assessment Instruments: What Can We Recommend to Practitioners in Children's and Young People's Cancer Care? , 2010, Cancer nursing.
[9] M. Naghizadeh,et al. Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis. , 2010, European journal of cancer care.
[10] A. Brugnera,et al. Use of 660-nm diode laser in the prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy. , 2010, Photomedicine and laser surgery.
[11] L. Chow,et al. Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients , 2010, Expert opinion on investigational drugs.
[12] Â. Maiolino,et al. Low‐power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation , 2010, European journal of haematology.
[13] P. Dulguerov,et al. Effect of topical morphine (mouthwash) on oral pain due to chemotherapy- and/or radiotherapy-induced mucositis: a randomized double-blinded study. , 2010, Journal of Palliative Medicine.
[14] G. Colella,et al. Efficacy of a Spray Compound Containing a Pool of Collagen Precursor Synthetic Amino Acids (L-Proline, L-Leucine, L-Lysine and Glycine) Combined with Sodium Hyaluronate to Manage Chemo/Radiotherapy-Induced Oral Mucositis: Preliminary Data of an Open Clinical Trial , 2010, International journal of immunopathology and pharmacology.
[15] W. Nadalin,et al. Prophylactic Low-energy Laser Application to Prevent Chemoradiation-induced Oral Mucositis: A Prospective and Randomized Trial , 2009 .
[16] R. Tishler,et al. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer , 2009, Cancer.
[17] D. Peterson,et al. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Liang Wang,et al. Effect of Yangyin Humo Decoction (养阴护膜饮) on oral mucomembranous reaction to radiotherapy , 2009, Chinese journal of integrative medicine.
[19] Sang‐wook Lee,et al. Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer , 2009, Cancer.
[20] C. Hsieh,et al. Effect of extracts from indigowood root (Isatis indigotica Fort.) on immune responses in radiation-induced mucositis. , 2009, Journal of alternative and complementary medicine.
[21] B. Mohanti,et al. A randomized double-blind phase III study of efficacy of lactobacillus CD2 lozenges in preventing radiation- and chemotherapy-induced oral mucositis in head and neck cancer patients: Interim analysis. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] H. Brincker. Prophylactic treatment with miconazole in patients highly predisposed to fungal infection. A placebo-controlled double-blind study. , 2009, Acta medica Scandinavica.
[23] C. Crawley,et al. Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial , 2009, Bone Marrow Transplantation.
[24] F. Eduardo,et al. Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy‐induced oral mucositis: Comparison between low and high/low power lasers , 2009, Lasers in surgery and medicine.
[25] D. Shillington,et al. Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: a randomized, placebo controlled feasibility study. , 2009, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[26] A. Kazemian,et al. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. , 2009, European journal of cancer care.
[27] P. Putwatana,et al. Relief of Radiation-Induced Oral Mucositis in Head and Neck Cancer , 2009, Cancer nursing.
[28] D. Gupta,et al. Oral mucositis in morning vs. evening irradiated patients: A randomised prospective study , 2009, International journal of radiation biology.
[29] A. Brunetto,et al. Low-level Infrared Laser Therapy in Chemotherapy-induced Oral Mucositis: A Randomized Placebo-controlled Trial in Children , 2009, Journal of pediatric hematology/oncology.
[30] S. Chuncharunee,et al. Pilot Study: Effects of Parenteral Glutamine Dipeptide Supplementation on Neutrophil Functions and Prevention of Chemotherapy-Induced Side-Effects in Acute Myeloid Leukaemia Patients , 2008, The Journal of international medical research.
[31] Jianji Pan,et al. A Randomized Controlled Multicenter Trial of Actovegin Against Acute Oral Mucositis Induced by Chemo-radiotherapy for Nasopharyngeal Carcinoma , 2008 .
[32] Yuhchyau Chen,et al. Palifermin Reduces Severe Oral Mucositis in Subjects with Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy , 2008 .
[33] K. Keum,et al. The Therapeutic Effect of Recombinant Human Epidermal Growth Factor (rhEGF) on Mucositis in Patients with Head and Neck Cancer Undergoing Radiotherapy with or without Chemotherapy: A Double-blind Placebo-controlled Prospective Phase II Multi-Institutional Clinical Trial , 2008 .
[34] L. A. Lopes,et al. Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients. , 2008, Photomedicine and laser surgery.
[35] K. Keum,et al. The therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients with head and neck cancer undergoing radiotherapy with or without chemotherapy: a double-blind placebo-controlled prospective phase II multi-institutional study , 2008 .
[36] D. Brizel,et al. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] A. Gillenwater,et al. Randomized, double-blind, placebo-controlled study of palifermin for the prevention of mucositis in patients receiving doxorubicin-based chemotherapy , 2008 .
[38] D. Peterson,et al. Prophylaxis of recurrent chemotherapy-induced oral mucositis: A phase II multicenter, randomized, placebo-controlled trial of recombinant human intestinal trefoil factor (rhITF) , 2008 .
[39] U. Rashad,et al. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer , 2008, The Journal of Laryngology & Otology.
[40] M. Paesmans,et al. The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies , 2008, Supportive Care in Cancer.
[41] V. Vitale,et al. Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. , 2008, European journal of cancer care.
[42] Y. Halvorsen,et al. Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant , 2008, Supportive Care in Cancer.
[43] J. Sørensen,et al. Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies , 2008, Cancer.
[44] A. Moghadamnia,et al. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. , 2008, The journal of contemporary dental practice.
[45] M. Vidyasagar,et al. Efficacy of He-Ne Laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[46] O. Ibrahimi,et al. Stevens‐Johnson syndrome: Pathogenesis, diagnosis, and management , 2008, Annals of medicine.
[48] G. Wassmer,et al. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML). , 2007, The Journal of infection.
[49] Naoko Inagaki. [Report on the treatment of infections complicating hematological diseases. Case 2. Two cases of deep-seated mycosis developing during chemotherapy of leukemia]. , 2007, The Japanese journal of antibiotics.
[50] F. Shidfar,et al. Effect of vitamin E on chemotherapy‐induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation , 2007 .
[51] Somkit Penpattanagul. Reduced incidence and severity of acute radiation mucositis by WF10 (IMMUNOKINE) as adjunct to standard of cure in the management of head & neck cancer patients. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[52] B. Sevinir,et al. Debridement could be a solution to promote healing of established oral mucositis in children , 2007, European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry.
[53] R. Pieters,et al. Protection against chemotherapy induced mucositis by TGF‐β2 in childhood cancer patients: Results from a randomized cross‐over study , 2007, Pediatric blood & cancer.
[54] T. Shea,et al. Evaluation of single-dose palifermin to reduce oral mucositis in fractionated total-body irradiation and high-dose chemotherapy with autologous peripheral blood progenitor cell transplantation , 2007 .
[55] A. Brunetto,et al. Influence of low‐energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy , 2007, Pediatric blood & cancer.
[56] G. Birgegard,et al. Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy—a randomized controlled trial , 2007, Supportive Care in Cancer.
[57] F. Eduardo,et al. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation , 2007, Supportive Care in Cancer.
[58] C. Barber,et al. Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis , 2007, Supportive Care in Cancer.
[59] D. McGuire,et al. Clinical Practice Guidelines for the Prevention and Treatment of Mucositis , 2007 .
[60] Renato Amaro Zangaro,et al. Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. , 2007, Blood.
[61] W. Dörr,et al. Efficacy of Wobe-Mugos® E for Reduction of Oral Mucositis after Radiotherapy , 2007, Strahlentherapie und Onkologie.
[62] K. Ang,et al. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. , 2007, International journal of radiation oncology, biology, physics.
[63] M. Baccarani,et al. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group , 2007, Bone Marrow Transplantation.
[64] D. Orbach,et al. Multicenter Randomized Trial of Chewing Gum For Preventing Oral Mucositis in Children Receiving Chemotherapy , 2007, Journal of pediatric hematology/oncology.
[65] C. Kalofonos,et al. Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study. , 2007, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[66] W. Jeon,et al. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. , 2007, Clinical nutrition.
[67] A. Carvalho,et al. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. , 2007, Oral oncology.
[68] D. Peterson,et al. Randomized, placebo‐controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline‐based chemotherapy , 2007, Cancer.
[69] A. McDonnell,et al. Palifermin: Role in the Prevention of Chemotherapy- and Radiation-Induced Mucositis , 2007, The Annals of pharmacotherapy.
[70] M. Minegishi,et al. Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy. , 2006, The Tohoku journal of experimental medicine.
[71] S. Clarke,et al. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[72] J. Donovan,et al. Venous Thromboembolism Prophylaxis in High Risk Medically Ill Patients; a Meta Analysis. , 2006 .
[73] T. Braun,et al. Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). , 2006, Blood.
[74] M. Ramos F.,et al. Administration of Ratanhia-based herbal oral care products for the prophylaxis of oral mucositis in cancer chemotherapy patients: a clinical trial , 2006, Evidence-based complementary and alternative medicine : eCAM.
[75] D. Fernandes,et al. Effect of low level helium-neon (He-Ne) laser therapy in the prevention & treatment of radiation induced mucositis in head & neck cancer patients. , 2006, The Indian journal of medical research.
[76] V. Gebski,et al. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial. , 2006, Australasian radiology.
[77] K. K. Cheng,et al. A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer. , 2006 .
[78] Jie-shou Li,et al. Oral Glutamine Ameliorates Chemotherapy-induced Changes of Intestinal Permeability and Does not Interfere with the Antitumor Effect of Chemotherapy in Patients with Breast Cancer: A Prospective Randomized Trial , 2006, Tumori.
[79] H. Boezen,et al. Preventive Intervention Possibilities in Radiotherapy- and Chemotherapy-induced Oral Mucositis: Results of Meta-analyses , 2006, Journal of dental research.
[80] L. Cerchietti,et al. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.
[81] N. Aaronson,et al. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly , 2006, Cancer.
[82] A. Lluch,et al. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[83] R. A’Hern,et al. Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer. , 2006, The British journal of radiology.
[84] Li‐Ching Lin,et al. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study. , 2006, International journal of radiation oncology, biology, physics.
[85] M. Chambers,et al. RK-0202 for radiation-induced oral mucositis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[86] E. Anaissie,et al. Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single dose velafermin (CG53135-05) for the prevention of oral mucositis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[87] J. Bourhis,et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[88] D. Maloney,et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation , 2006, Bone Marrow Transplantation.
[89] Robert L. White,et al. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. , 2006, The journal of supportive oncology.
[90] S. Elad,et al. Oral candidiasis prevention in transplantation patients: a comparative study , 2006, Clinical transplantation.
[91] J. Shah,et al. Double‐Blind, Placebo‐Controlled, Randomized Trial of Granulocyte‐Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer , 2006, Cancer journal.
[92] S. Elad,et al. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation , 2006, Bone Marrow Transplantation.
[93] J. Cooper,et al. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90‐03 , 2006, Head & neck.
[94] N. Magné,et al. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). , 2006, International journal of radiation oncology, biology, physics.
[95] A. Sasse,et al. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. , 2006, International journal of radiation oncology, biology, physics.
[96] T. Morimoto,et al. Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy. , 2006, European journal of cancer care.
[97] A. Monnier,et al. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study. , 2006, International journal of radiation oncology, biology, physics.
[98] A. Glasmacher,et al. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. , 2006, The Journal of antimicrobial chemotherapy.
[99] L. Janković,et al. Mucositis prevention by improved dental care in acute leukemia patients , 2006, Supportive Care in Cancer.
[100] P. Gøtzsche,et al. Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations , 2006, Trials.
[101] E. Estey,et al. Open-Label, Randomized Comparison of Itraconazole versus Caspofungin for Prophylaxis in Patients with Hematologic Malignancies , 2006, Antimicrobial Agents and Chemotherapy.
[102] J. Garvin,et al. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study , 2005, Bone Marrow Transplantation.
[103] R. Lewensohn,et al. Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy , 2005, Medical oncology.
[104] A. Sevinç,et al. Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy. , 2005, Journal of the National Medical Association.
[105] T. Shaw,et al. Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil. , 2005, Journal of clinical nursing.
[106] T. Shouman,et al. A randomized study of accelerated fractionation radiotherapy with and without mitomycin C in the treatment of locally advanced head and neck cancer. , 2005, Journal of the Egyptian National Cancer Institute.
[107] N. Kakimoto,et al. Effectiveness of Cepharanthin in decreasing interruptions during radiation therapy for oral cancer , 2005, Oral Radiology.
[108] A. Bezjak,et al. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis , 2005, Head & neck.
[109] R. Herrmann,et al. Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation , 2005, Bone Marrow Transplantation.
[110] N. Chao,et al. Pharmacokinetic and Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing a Bone Marrow or Peripheral Stem Cell Transplant , 2005, Antimicrobial Agents and Chemotherapy.
[111] P. Fox,et al. Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation , 2005, Bone Marrow Transplantation.
[112] J. Bocková,et al. The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT—results of a randomized multicentre study , 2005, Supportive Care in Cancer.
[113] C. Zielinski,et al. Palifermin and chemotherapy-induced oral mucositis. , 2005, The New England journal of medicine.
[114] A. Awada,et al. Palifermin and chemotherapy-induced oral mucositis. , 2005, The New England journal of medicine.
[115] Y. Ikeda,et al. Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients , 2005, Supportive Care in Cancer.
[116] C. Abboud,et al. Phase I/II Randomized Trial Evaluating the Safety and Clinical Effects of Repifermin Administered to Reduce Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation , 2004, Clinical Cancer Research.
[117] K. K. Cheng,et al. Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngeal mucositis. , 2004, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[118] Thomas J Walsh,et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. , 2004, The New England journal of medicine.
[119] A. Koong,et al. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. , 2004, International journal of radiation oncology, biology, physics.
[120] F. Spijkervet,et al. Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II study. , 2004, Anticancer research.
[121] M. Zelefsky,et al. Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): Impact on mucositis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[122] D. Peterson,et al. Phase III study: AES-14 in patients at risk for mucositis secondary to anthracycline-based chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] C. Chuah,et al. A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation , 2004, Bone Marrow Transplantation.
[124] M. Piccart,et al. Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers , 2004, Anti-cancer drugs.
[125] R. Sylvester,et al. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. , 2004, European journal of cancer.
[126] T. Fleming,et al. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. , 2004, Leukemia research.
[127] J. Sierra,et al. Low‐dose amphotericin b lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies – a randomized, controlled trial , 2004, European journal of haematology.
[128] D. McGuire,et al. Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis , 2004, Cancer.
[129] H. Worthington,et al. A survey of current practice with regard to oral care for children being treated for cancer. , 2004, European journal of cancer.
[130] A. Chang,et al. Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care. , 2004, European journal of cancer.
[131] L. Elting,et al. Perspectives on cancer therapy‐induced mucosal injury , 2004, Cancer.
[132] J. Epstein,et al. Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy , 2004, Supportive Care in Cancer.
[133] J. Fleck,et al. Protective effect of alpha‐tocopherol in head and neck cancer radiation‐induced mucositis: A double‐blind randomized trial , 2004, Head & neck.
[134] A. Garden,et al. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. , 2004, International journal of radiation oncology, biology, physics.
[135] Kiyohito Yoshida,et al. Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis. , 2004, Anticancer research.
[136] D. Rades,et al. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[137] S. Liou,et al. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[138] W. Leisenring,et al. Cyclophosphamide metabolism is affected by azole antifungals. , 2004, Blood.
[139] W. Leisenring,et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. , 2004, Blood.
[140] L. Harrison,et al. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis , 2004, Supportive Care in Cancer.
[141] H. Rugo,et al. Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule , 2004, Cancer Chemotherapy and Pharmacology.
[142] L. Harrison,et al. Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer. , 2003, Seminars in oncology.
[143] P. Wischmeyer,et al. Prevention of chemotherapy and radiation toxicity with glutamine. , 2003, Cancer treatment reviews.
[144] A. Chang,et al. Palliation of Oral Mucositis Symptoms in Pediatric Patients Treated With Cancer Chemotherapy , 2003, Cancer nursing.
[145] F. Foroudi,et al. Radiation induced mucositis: co-ordinating a research agenda. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).
[146] G. Grant,et al. Oral and intestinal mucositis — causes and possible treatments , 2003, Alimentary pharmacology & therapeutics.
[147] I. Chitapanarux,et al. Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[148] D. Cella,et al. Evaluation of pain associated with oral mucositis during the acute period after administration of high‐dose chemotherapy , 2003, Cancer.
[149] A. Gadducci,et al. Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[150] T. Fleming,et al. A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial) , 2003, Leukemia & lymphoma.
[151] S. Sonis,et al. Antimicrobial therapy to prevent or treat oral mucositis. , 2003, The Lancet. Infectious diseases.
[152] H. Ulmer,et al. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution , 2003, Annals of Hematology.
[153] L. D. de Souza,et al. Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia. , 2003, Pesquisa odontologica brasileira = Brazilian oral research.
[154] Carlos Neutzling Lehn,et al. Efeito da clorexidina na mucosite induzida por radioterapia em câncer de cabeça e pescoço , 2003 .
[155] A. Hinke,et al. Randomized Phase III Trial of Postoperative Radiochemotherapy ± Amifostine in Head and Neck Cancer , 2003, Strahlentherapie und Onkologie.
[156] K. Dardoufas,et al. Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. , 2003, Oral oncology.
[157] C. Serdar,et al. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[158] R. E. Clark,et al. A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation , 2003, Bone Marrow Transplantation.
[159] Bingyi Wu,et al. A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy. , 2003, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.
[160] E. D. de Vries,et al. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial , 2003, British Journal of Cancer.
[161] A. Kramer,et al. Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study. , 2003, The Journal of hospital infection.
[162] O. Nanni,et al. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[163] E. Estey,et al. Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[164] C. Gwede,et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[165] Takeshi Kondo,et al. 造血器悪性腫瘍患者における真菌症予防効果の検討 : イトラコナゾール(ITCZ)投与量の解析 , 2003 .
[166] B. M. Biswal,et al. Topical application of honey in the management of radiation mucositis. A Preliminary study , 2003, Supportive Care in Cancer.
[167] E. Aktas,et al. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers. , 2003, Japanese journal of clinical oncology.
[168] Yu Shen,et al. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction , 2003, Cancer.
[169] V. Chang,et al. Symptom Control , 2003, Cancer investigation.
[170] N. Facione,et al. Radiation-Induced Mucositis: A Randomized Clinical Trial of Micronized Sucralfate Versus Salt & Soda Mouthwashes , 2003, Cancer investigation.
[171] J. Bourhis,et al. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. , 2002, Seminars in oncology.
[172] P. Levendag,et al. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation. , 2002, Seminars in oncology.
[173] G. Phillips. The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation. , 2002, Seminars in oncology.
[174] G. Salles,et al. Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma , 2002, Bone Marrow Transplantation.
[175] B. Procházka,et al. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study , 2002, Bone Marrow Transplantation.
[176] Noel T. Whelan,et al. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. , 2002, Journal of clinical laser medicine & surgery.
[177] L. Cerchietti,et al. Effect of topical morphine for mucositis‐associated pain following concomitant chemoradiotherapy for head and neck carcinoma , 2002, Cancer.
[178] H. Joensuu,et al. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study. , 2002, International journal of radiation oncology, biology, physics.
[179] U. Haus,et al. rhGM-CSF in the treatment of radiotherapy induced mucositis-prospective randomized, double-blind study to investigate the feasibility and effectiveness of rhGM-CSF in patients with head and neck cancer , 2002 .
[180] G. Giaccone,et al. Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[181] D. Tu,et al. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[182] U. Wollina,et al. Zur Prophylaxe und Therapie der Radiodermatitis und Radiomucositis , 2002 .
[183] F. Mosca,et al. Antifungal prophylaxis in liver transplant recipients: a randomized placebo‐controlled study , 2002, Transplant international : official journal of the European Society for Organ Transplantation.
[184] A. Molassiotis,et al. An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: a pilot study. , 2002, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[185] Hung-Ming Wang,et al. Cisplatin, tegafur, and leucovorin , 2002, Cancer.
[186] A. Angius,et al. [Prevention of periodontopathy and oral mucositis during antineoplastic chemotherapy. Clinical study]. , 2002, Minerva stomatologica.
[187] Christian Domenge,et al. A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis. , 2002, Oral oncology.
[188] P. Ellis,et al. A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[189] M. Sanz,et al. Mouth-washings with recombinant human granulocyte–macrophage colony stimulating factor (rhGM-CSF) do not improve grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study , 2002, Bone Marrow Transplantation.
[190] R. Schilsky,et al. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[191] M. Puglisi,et al. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.
[192] D. Neuberg,et al. A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation , 2002, Bone Marrow Transplantation.
[193] M. Ferrill,et al. Granulocyte Macrophage—Colony Stimulating Factor and Oral Mucositis , 2002, The Annals of pharmacotherapy.
[194] J. Perfect,et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children , 2002, The Pediatric infectious disease journal.
[195] A. Begg,et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation , 2002, British Journal of Cancer.
[196] Douglas G Altman,et al. Meta-analyses involving cross-over trials: methodological issues. , 2002, International journal of epidemiology.
[197] E. Anaissie,et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. , 2002, The New England journal of medicine.
[198] J. Epstein,et al. A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy , 2002, Head & neck.
[199] E. Perez,et al. Phase I Trial of Edatrexate in Advanced Breast and Other Cancers , 2002, Cancer investigation.
[200] G. Oster,et al. Defining Clinically Meaningful Outcomes in the Evaluation of New Treatments for Oral Mucositis: Oral Mucositis Patient Provider Advisory Board , 2002, Cancer investigation.
[201] G. Lockwood,et al. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.
[202] J. Wheeler,et al. Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07). , 2001, International journal of radiation oncology, biology, physics.
[203] H. Ulmer,et al. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. , 2001, European journal of cancer.
[204] W. Scheithauer,et al. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial. , 2001, European journal of cancer.
[205] A. Mubarak,et al. Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer. , 2001, European journal of cancer.
[206] A. Molassiotis,et al. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. , 2001, European journal of cancer.
[207] D. Brachman,et al. A phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients. Final results of RTOG 97-09 , 2001 .
[208] R. Rosso,et al. Sucralfate in the treatment of chemotherapy-induced stomatitis: a double-blind, placebo-controlled pilot study. , 2001, Anticancer research.
[209] N. Senzer,et al. Benzydamine HCl for prophylaxis of radiation‐induced oral mucositis , 2001, Cancer.
[210] S. Dische,et al. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[211] K. Vandewoude,et al. Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients. , 2001, The Journal of antimicrobial chemotherapy.
[212] R. Danesi,et al. 5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer , 2001, Oncology.
[213] S. Sonis,et al. Topical Transforming Growth Factor-&bgr;3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors , 2001, Journal of immunotherapy.
[214] M. Forni,et al. Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[215] P. Levendag,et al. Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study. , 2001, International journal of radiation oncology, biology, physics.
[216] C. Conradt,et al. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers , 2001, Cancer Chemotherapy and Pharmacology.
[217] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials , 2001, Annals of Internal Medicine.
[218] G. Browman,et al. Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials. , 2001, International journal of radiation oncology, biology, physics.
[219] C. Bokemeyer,et al. A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation , 2001, British Journal of Cancer.
[220] A. Bockisch,et al. Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer--a prospective,randomized, placebo-controlled, double-blind study. , 2001, The British journal of oral & maxillofacial surgery.
[221] C. Bennett,et al. Economic Analysis of Amifostine as Adjunctive Support for Patients with Advanced Head and Neck Cancer: Preliminary Results from a Randomized Phase II Clinical Trial from Germany , 2001, Cancer investigation.
[222] H. Kantarjian,et al. Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with Leukemia , 2001, Leukemia & lymphoma.
[223] E. Bow,et al. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study. , 2000, The Journal of antimicrobial chemotherapy.
[224] D. Brizel,et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[225] J. Knox,et al. Chemotherapy-Induced Oral Mucositis , 2000, Drugs & aging.
[226] D. Lewis,et al. Oral management of patients following oncology treatment: literature review. , 2000, The British journal of oral & maxillofacial surgery.
[227] Yasunori Sato,et al. A Study of the Prophylactic Effect of the Oral Antifungal Agent Itraconazole against Oral Cavity Candidiasis in Patients Receiving Radiation Therapy for Oral Cavity Carcinoma , 2000 .
[228] J. Harousseau,et al. Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B , 2000, Antimicrobial Agents and Chemotherapy.
[229] S. Paul,et al. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. , 2000, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[230] T J Walsh,et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[231] V. Georgoulias,et al. Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[232] R. Collins,et al. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group , 2000, Bone Marrow Transplantation.
[233] D. Touw,et al. Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial , 2000, Bone Marrow Transplantation.
[234] R. Crevoisier,et al. A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma. , 2000, International journal of radiation oncology, biology, physics.
[235] R. Negrin,et al. Effect of oral glutamine supplementation during bone marrow transplantation. , 2000, JPEN. Journal of parenteral and enteral nutrition.
[236] M. Territo,et al. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. , 2000, The American journal of medicine.
[237] M. Nucci,et al. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[238] F. Fang,et al. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. , 2000, International journal of radiation oncology, biology, physics.
[239] J. Crawford,et al. Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy. , 1999, Cytokines, cellular & molecular therapy.
[240] T. Büchner,et al. Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine , 1999, Mycoses.
[241] D. Brizel,et al. Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers , 1999, Head & neck.
[242] R. Nishimura,et al. Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: an interim look at a randomized, double-blind, placebo-controlled trial. , 1999, Cytokines, cellular & molecular therapy.
[243] P. Plevova. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. , 1999, Oral oncology.
[244] S. Durrant,et al. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia , 1999 .
[245] L. Peters,et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[246] V. Darcourt,et al. Low-energy He/Ne laser in the prevention of radiation-induced mucositis , 1999, Supportive Care in Cancer.
[247] J. Sloan,et al. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. , 1999, American journal of clinical oncology.
[248] R. Kaul,et al. The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers--a clinical phase-III randomized trial. , 1999, Indian journal of cancer.
[249] A. Prentice,et al. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies , 1999 .
[250] F. Spijkervet,et al. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[251] H. van Tinteren,et al. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology. , 1999, Journal of clinical pathology.
[252] M. Ertem,et al. Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy. , 1999, Medical and pediatric oncology.
[253] H. Lippert,et al. High-dose therapy with combined 5-fluorouracil and folinic acid with and without amifostine in the treatment of patients with metastatic colorectal carcinoma , 1999, International Journal of Colorectal Disease.
[254] A. Favero,et al. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[255] E. Bow,et al. Randomized Placebo-Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy , 1999 .
[256] S. Khan,et al. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia. , 1998, The American journal of medicine.
[257] W. Millesi,et al. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer. , 1998, International journal of radiation oncology, biology, physics.
[258] A. Ganser,et al. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial , 1998, Bone Marrow Transplantation.
[259] P. Anderson,et al. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy , 1998, Cancer.
[260] R. Clark,et al. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis , 1998, Bone Marrow Transplantation.
[261] H. Böttcher,et al. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy , 1998, Supportive Care in Cancer.
[262] B. Hodgkinson,et al. The Effectiveness of Strategies for Preventing and Treating Chemotherapy and Radiation Induced Oral Mucositis in Patients with Cancer; A systematic Review , 1998 .
[263] E. Zubizarreta,et al. Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[264] J. Büntzel,et al. Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[265] R. Symonds,et al. Treatment-induced mucositis: an old problem with new remedies. , 1998, British Journal of Cancer.
[266] S. Sone,et al. Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis. , 1998, International journal of radiation oncology, biology, physics.
[267] J. Büntzel,et al. Radiochemotherapy with amifostine cytoprotection for head and neck cancer , 1998, Supportive Care in Cancer.
[268] R. Willers,et al. Patient-controlled versus staff-controlled analgesia with pethidine after allogeneic bone marrow transplantation , 1998, Pain.
[269] B. Kornhuber,et al. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer. , 1997, The Journal of antimicrobial chemotherapy.
[270] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[271] F. Lévi,et al. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer , 1997, The Lancet.
[272] G. Lodi,et al. Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation. , 1997, Oral oncology.
[273] C. Chapman,et al. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation , 1997, Pain.
[274] S. Haq,et al. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis. , 1997, Journal of pain and symptom management.
[275] O. Lortholary,et al. Antifungal prophylaxis during neutropenia and immunodeficiency , 1997, Clinical microbiology reviews.
[276] C. Chapman,et al. Differences among patients in opioid self-administration during bone marrow transplantation , 1997, Pain.
[277] D. Cowen,et al. Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. , 1997, International journal of radiation oncology, biology, physics.
[278] J. Kirkwood,et al. A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study. , 1997, American journal of clinical oncology.
[279] P. Novotny,et al. A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation‐induced mucositis , 1997, Cancer.
[280] P. Ziegler,et al. Einsatz von Fluconazol zur antimykotischen Prophylaxe bei Bestrahlungen von Patienten mit Kopf‐Hals‐Tumoren , 1997 .
[281] P. Novotny,et al. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[282] S. Spencer,et al. Sucralfate for radiation mucositis: results of a double-blind randomized trial. , 1997, International journal of radiation oncology, biology, physics.
[283] H. Thaler,et al. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. , 1996, The Journal of pediatrics.
[284] E. Anaissie,et al. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[285] P. McIlroy. Radiation mucositis: a new approach to prevention and treatment. , 1996, European journal of cancer care.
[286] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[287] J. Paul,et al. The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. , 1996, British Journal of Cancer.
[288] D. Buell,et al. Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients. , 1996, Chemotherapy.
[289] A. Dueñas-González,et al. Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study. , 1996, Bone marrow transplantation.
[290] P. Zorat,et al. [Can the prophylactic treatment of mycotic mucositis improve the time of performing radiotherapy in head and neck tumors?]. , 1996, La Radiologia medica.
[291] D. Reece,et al. Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants. , 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[292] J. O'fallon,et al. Prospective evaluation of a chamomile mouthwash for prevention of 5‐FU‐induced oral mucositis , 1996, Cancer.
[293] D. Machin,et al. Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party. , 1996, British Journal of Cancer.
[294] M. Richardson,et al. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours. , 1996, The British journal of oral & maxillofacial surgery.
[295] A. Barasch,et al. Helium‐neon laser effects on conditioning‐induced oral mucositis in bone marrow transplantation patients , 1995, Cancer.
[296] G. Brufman,et al. 1234 Can zinc picolinate in patients receiving chemotherapy for metastatic colorectal carcinoma prevent stomatitis , 1995 .
[297] S. P. Reddy,et al. Protection from Radiation-Induced Oral Mucositis by Misoprostol, a Prostaglandin E(1) Analog: A Placebo-Controlled, Double-Blind Clinical Trial. , 1995, American journal of therapeutics.
[298] P. Pichna,et al. Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial. , 1995, Journal of chemotherapy.
[299] D. Kerr,et al. 'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group. , 1995, European journal of cancer.
[300] Gary W. Donaldson,et al. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial , 1995, PAIN®.
[301] M. McGurk,et al. The Effect of Epidermal Growth Factor Mouthwash on Cytotoxic‐Induced Oral Ulceration: A Phase I Clinical Trial , 1995, American journal of clinical oncology.
[302] K. Chow,et al. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[303] A. Schaffner,et al. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. , 1995, The Journal of infectious diseases.
[304] P. Pitel,et al. Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group. , 1995, The Journal of pediatrics.
[305] G. Rosner,et al. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study. , 1995, Cytokine.
[306] M. Elia,et al. A pilot study of oral glutamine supplementation in patients receiving bone marrow transplants. , 1995, Clinical nutrition.
[307] J. Singer,et al. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. , 1995, Bone marrow transplantation.
[308] R. Haznedar,et al. Prophylactic use of fluconazole in neutropenic cancer patients. , 1995, Postgraduate medical journal.
[309] J. Strang,et al. Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma. , 1995, Leukemia & lymphoma.
[310] A. Gratwohl,et al. Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients , 1995, Supportive Care in Cancer.
[311] M. Katano,et al. Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis , 1995, Surgery Today.
[312] D. Stevens,et al. Therapy for opportunistic fungal infections: past, present and future. , 1995, Indian journal of cancer.
[313] S. Pyrhönen,et al. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. , 1995, British Journal of Cancer.
[314] D. Niethammer,et al. Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes , 1995, Mycoses.
[315] J. O'fallon,et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[316] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[317] H. Sauerwein,et al. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy‐induced toxicity , 1994, Cancer.
[318] R. Collins,et al. Sequential administration of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a phase I/II multicenter study. , 1994, Blood.
[319] Sarah E. Jebb,et al. 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation. , 1994, British Journal of Cancer.
[320] H. Joensuu,et al. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study. , 1994, International Journal of Radiation Oncology, Biology, Physics.
[321] S. Cascinu,et al. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. , 1994, European journal of cancer. Part B, Oral oncology.
[322] O. Ringdén,et al. Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies. , 1994, Transplantation proceedings.
[323] M. Moroni,et al. Allopurinol Mouthwashes in the Treatment of 5‐Fluorouracil‐Induced Stomatitis , 1994, American journal of clinical oncology.
[324] T. Barbui,et al. Preventing Fungal Infection in Neutropenic Patients with Acute Leukemia: Fluconazole Compared with Oral Amphotericin B , 1994, Annals of Internal Medicine.
[325] A. B. Prasad,et al. British National Formulary , 1994 .
[326] E. Anaissie,et al. Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B , 1994, Cancer.
[327] J. Ninane,et al. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies , 1994, European Journal of Clinical Microbiology and Infectious Diseases.
[328] J. Meis,et al. Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients , 1994, Infection.
[329] E. Anaissie,et al. Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection , 1994, European Journal of Clinical Microbiology and Infectious Diseases.
[330] J. Epstein,et al. The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. , 1994, International journal of radiation oncology, biology, physics.
[331] P. Chandrasekar,et al. The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team. , 1994, The Journal of antimicrobial chemotherapy.
[332] H. Sakamaki,et al. Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy‐induced neutropenic patients with haematological malignancies Vergleichende Studie über , 1993, Mycoses.
[333] J. W. Davis,et al. Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report. , 1993, Oral surgery, oral medicine, and oral pathology.
[334] C. Loprinzi,et al. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5‐fluorouracil‐related stomatitis , 1993, Cancer.
[335] C. Verdi. Cancer Therapy and Oral Mucositis , 1993, Drug safety.
[336] T. Yamada,et al. Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B. , 1993, Internal medicine.
[337] G. Laurent,et al. Prevention of Regimen-Related Toxicities After Bone Marrow Transplantation by Pentoxifylline: A Prospective, Randomized Trial , 1993 .
[338] N. Coombe,et al. Propantheline prevention of mucositis from etoposide. , 1993, Bone marrow transplantation.
[339] G. Mufti,et al. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. , 1993, The Journal of antimicrobial chemotherapy.
[340] B. Labar,et al. Prostaglandin E2 for prophylaxis of oral mucositis following BMT. , 1993, Bone marrow transplantation.
[341] H. Horowitz,et al. Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial , 1993, Annals of Internal Medicine.
[342] D. Reece,et al. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. , 1992, Oral surgery, oral medicine, and oral pathology.
[343] B. Coda,et al. Patient-controlled analgesic infusions: alfentanil versus morphine , 1992, Pain.
[344] R. Redman,et al. Vitamin E in the treatment of chemotherapy-induced mucositis. , 1992, The American journal of medicine.
[345] J. Palmblad,et al. Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias , 1992, Journal of internal medicine.
[346] J. L. Goodman,et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.
[347] K. Syrjala,et al. Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: a controlled clinical trial , 1992, Pain.
[348] H. Hill,et al. Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain , 1991, Pain.
[349] M. Paesmans,et al. Chemoprophylaxis of Fungal Infections in Granulocytopenic Patients Using Fluconazole vs Oral Amphotericin B , 1991 .
[350] D. Longo,et al. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study. , 1991, Archives of internal medicine.
[351] W. Kern,et al. Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia , 1991, Infection.
[352] J. Verhoef,et al. A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia. , 1991, The Journal of antimicrobial chemotherapy.
[353] L. Loftus,et al. The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis. , 1991, Oral surgery, oral medicine, and oral pathology.
[354] T. Therneau,et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[355] B. Coda,et al. Patient‐controlled analgesic administration. A comparison of steady‐state morphine infusions with bolus doses , 1991, Cancer.
[356] C. Noguès,et al. Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial. , 1991, Bone marrow transplantation.
[357] G. Schaison,et al. Prevention of Gram‐positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children , 1990, British journal of haematology.
[358] S. Kenny,et al. Effect of two oral care protocols on the incidence of stomatitis in hematology patients , 1990, Cancer nursing.
[359] G. Michelone,et al. Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study. , 1990, Microbiologica.
[360] I. Narabayashi,et al. [Clinical evaluation of sodium alginate on oral mucositis associated with radiotherapy]. , 1990, Nihon Gan Chiryo Gakkai shi.
[361] J. Gérain,et al. Oral Treatment of Oropharyngeal Candidiasis with Nystatin Versus Ketoconazole in Cancer Patients , 1990 .
[362] D. Alberts,et al. A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial. , 1990 .
[363] T. Therneau,et al. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5‐fluorouracil‐induced stomatitis , 1990, Cancer.
[364] D. Blakeslee,et al. Treatment of Radiation- and Chemotherapy-Induced Stomatitis , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[365] H. Sinzinger,et al. Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositis. , 1990, The British journal of oral & maxillofacial surgery.
[366] G. Samonis,et al. Prophylaxis of oropharyngeal candidiasis with fluconazole. , 1990, Reviews of infectious diseases.
[367] F. Meunier,et al. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. , 1990, Reviews of infectious diseases.
[368] G. Ferretti,et al. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. , 1990, Oral surgery, oral medicine, and oral pathology.
[369] C. Erlichman. Fluorouracil and leucovorin for metastatic colorectal cancer. , 1990, Journal of chemotherapy.
[370] C. Benedetti,et al. Self-administration of morphine in bone marrow transplant patients reduces drug requirement , 1990, Pain.
[371] H. Mizoguchi,et al. Prophylactic and therapeutic effects of oral administration of amphotericin B in mycosis associated with hematologic diseases. Study Group of Mycosis in Hematologic Disease. , 1990, The Japanese journal of antibiotics.
[372] P. Beatty,et al. Long term effects and quality of life in children and adults after marrow transplantation. , 1989, Bone marrow transplantation.
[373] A. Prentice,et al. Prophylaxis of Fungal Infections with Itraconazole during Remission‐Induction Therapy , 1989, Mycoses.
[374] Y. Wahlin. Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia. , 1989, Oral surgery, oral medicine, and oral pathology.
[375] J. Epstein,et al. Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. , 1989, International journal of radiation oncology, biology, physics.
[376] C. Crumpacker,et al. Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions , 1989, Antimicrobial Agents and Chemotherapy.
[377] D. Weisdorf,et al. Effectiveness of oral chlorhexidine for reducing stomatitis in a pediatric bone marrow transplant population. , 1989, Pediatric dentistry.
[378] T. Pajak,et al. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). , 1989, International journal of radiation oncology, biology, physics.
[379] F. Spijkervet,et al. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. , 1989, Oral surgery, oral medicine, and oral pathology.
[380] P. Parikh,et al. Comparison of clotrimazole with nystatin in preventing oral candidiasis in neutropaenic patients. , 1988, The Indian journal of medical research.
[381] S. George,et al. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. , 1988, The Journal of pediatrics.
[382] G. Ferretti,et al. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse. , 1988, Bone marrow transplantation.
[383] A. Berger,et al. Development, testing, and application of the oral assessment guide. , 1988, Oncology nursing forum.
[384] E. Mills,et al. The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis. , 1988, British Journal of Cancer.
[385] C. Erlichman,et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[386] J. Connors,et al. Ketoconazole Versus Nystatin as Prophylaxis Against Fungal Infection for Lymphoma Patients Receiving Chemotherapy , 1987, American journal of clinical oncology.
[387] L. Dudjak. Mouth care for mucositis due to radiation therapy , 1987, Cancer nursing.
[388] L. Dupuis,et al. Comparative Evaluation of Benzydamine Oral Rinse in Children with Antineoplastic-Induced Stomatitis , 1987, Drug intelligence & clinical pharmacy.
[389] G. Ferretti,et al. Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. , 1987, Journal of the American Dental Association.
[390] R. Abrams,et al. Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study. , 1987, Archives of internal medicine.
[391] E. Bottone,et al. Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy. Results of a double-blind study. , 1986, The American journal of medicine.
[392] J. Rosenman,et al. Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers. , 1986, Archives of otolaryngology--head & neck surgery.
[393] J. Kim,et al. Benzydamine HCl, A New Agent for the Treatment of Radiation Mucositis of the Oropharynx , 1986, American journal of clinical oncology.
[394] G. Bodey,et al. Prophylaxis of oropharyngeal candidiasis with clotrimazole. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[395] D. Shepp,et al. Comparative Trial of Ketoconazole and Nystatin for Prevention of Fungal Infection in Neutropenic Patients Treated in a Protective Environment , 1985 .
[396] A. Belch,et al. Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen. , 1985, Oral surgery, oral medicine, and oral pathology.
[397] J. Anderson,et al. Ketoconazole prophylaxis in patients with solid tumours receiving aggressive immunosuppressive therapy. An open randomized comparison between 200 mg/d and 400 mg/d doses. , 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[398] J. Kersey,et al. Empirical antibacterial therapy in febrile, granulocytopenic bone marrow transplant patients , 1984, Antimicrobial Agents and Chemotherapy.
[399] F. Meunier-Carpentier. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections. , 1984, The American journal of medicine.
[400] C. Kauffman,et al. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients. , 1984, Archives of internal medicine.
[401] E. Holst. Natamycin and nystatin for treatment of oral candidiasis during and after radiotherapy. , 1984, The Journal of prosthetic dentistry.
[402] R. Quintiliani,et al. Prophylaxis of oral candidiasis with clotrimazole troches. , 1984, Archives of internal medicine.
[403] D. Bartley,et al. Ketoconazole and candidiasis: a controlled study. , 1983, The Journal of infectious diseases.
[404] D. Kaiser,et al. Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies. , 1983, The American journal of medicine.
[405] H. Brincker. Prevention of Mycosis in Granulocytopenic Patients with Prophylactic Ketoconazole Treatment/Prophylaktische Mykose‐Behandlung mit Ketoconazol bei granulozytopenischen Patienten , 1983, Mykosen.
[406] R. Storb,et al. Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.
[407] S. Howell,et al. Effect of allopurinol on the toxicity of high‐dose 5‐fluorouracil administered by intermittent bolus injection , 1983, Cancer.
[408] H. Prentice,et al. KETOCONAZOLE VERSUS NYSTATIN PLUS AMPHOTERICIN B FOR FUNGAL PROPHYLAXIS IN SEVERELY IMMUNOCOMPROMISED PATIENTS , 1982, The Lancet.
[409] B. Toth,et al. Effect of intravenous hyperalimentation and oral care on the development of oral stomatitis during cancer chemotherapy , 1982 .
[410] D. Armstrong,et al. Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial. , 1981, Annals of internal medicine.
[411] D. Sleijfer,et al. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. , 1980, European journal of cancer.
[412] G. Bodey,et al. Oropharyngeal candidiasis treated with a troche form of clotrimazole. , 1979, Archives of internal medicine.
[413] G. Harding,et al. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. , 1979, The American journal of medicine.
[414] C. Laymon,et al. Letterer-Siwe disease. , 1949, Archives of dermatology and syphilology.
[415] F. Roelfsema,et al. multi-center study. , 2011 .
[416] Y. Matsuyama,et al. A MULTICENTRE STUDY , 2010 .
[417] K. Alavi,et al. Efficacy of topical phenytoin on chemotherapy-induced oral mucositis; a pilot study , 2010, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences.
[418] M. Henderson,et al. The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients , 2009, European Journal of Clinical Nutrition.
[419] M. C. Rodrigues,et al. Use of therapeutic laser for prevention and treatment of oral mucositis. , 2009, Brazilian dental journal.
[420] M. Brundage,et al. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). , 2009, International journal of radiation oncology, biology, physics.
[421] A. Carvalho,et al. A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis. , 2009, Journal of oral science.
[422] T. Intragumtornchai,et al. The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study , 2009 .
[423] G. Calais,et al. Comparison of the efficacy and safety of miconazole 50‐mg mucoadhesive buccal tablets with miconazole 500‐mg gel in the treatment of oropharyngeal candidiasis , 2008 .
[424] J. Shetty,et al. The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: a randomized control trial. , 2008, Journal of cancer research and therapeutics.
[425] A. El-Housseiny,et al. The effectiveness of vitamin "E" in the treatment of oral mucositis in children receiving chemotherapy. , 2007, The Journal of clinical pediatric dentistry.
[426] Vazhenin Av,et al. [Effectiveness of different regimes of combined treatment (cisplatin+ radiotherapy) for intraoral and oropharyngeal cancer]. , 2007 .
[427] M. Erfan,et al. Allopurinol mouthwash for prevention or alleviation radiotherapy induced oral mucositis: a randomized, placebo-controlled trial , 2007 .
[428] J. Bauer,et al. Palifermin improves severe mucositis, swallowing problems, nutrition impact symptoms, and length of stay in patients undergoing hematopoietic stem cell transplantation , 2006, Supportive Care in Cancer.
[429] D. Reinhardt,et al. Parenteral nutrition is not superior to replacement fluid therapy for the supportive treatment of chemotherapy induced oral mucositis in children. , 2006, European journal of cancer.
[430] G. V. Ramana,et al. A Randomised, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy of MF 5232 (Mucotrol™), a Concentrated Oral Gel Wafer, in the Treatment of Oral Mucositis , 2005, Drugs in R&D.
[431] K. Dardoufas,et al. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy , 2005, Supportive Care in Cancer.
[432] M. Kalin,et al. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[433] E. Perez,et al. Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy , 2004, Investigational New Drugs.
[434] J. Bourhis. LA CASPOFUNGINE DANS LE TRAITEMENT EMPIRIQUE DES INFECTIONS FONGIQUES , 2004 .
[435] M. Ertekin,et al. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study. , 2004, International journal of radiation oncology, biology, physics.
[436] G. Calais,et al. Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial. , 2004, International journal of radiation oncology, biology, physics.
[437] C. Grau,et al. Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy. , 2003, Seminars in radiation oncology.
[438] C. Beyan,et al. Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[439] D. Eisen,et al. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy , 2003, Bone Marrow Transplantation.
[440] G. Mantovani,et al. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. , 2003, Oncology reports.
[441] P. Chiusolo,et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. , 2003, Haematologica.
[442] S. D. Mitrokhin. [Itraconazole (Orungal) in the treatment of mycotic infections in oncologic patients]. , 2003, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic].
[443] O. Ringdén. Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital. , 2002, The Journal of antimicrobial chemotherapy.
[444] P. Cagnoni. Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. , 2002, The Journal of antimicrobial chemotherapy.
[445] C. Miaskowski,et al. A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer. , 2002, Oncology nursing forum.
[446] G. Pond,et al. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial , 2002, Supportive Care in Cancer.
[447] M. Piccart,et al. An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes. , 2002, European journal of cancer.
[448] J. Büntzel,et al. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer. , 2002, Seminars in radiation oncology.
[449] K. Bjordal,et al. Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study. , 2001, Acta oncologica.
[450] O. Zambrano,et al. Prevención oral en niños con cáncer: efectividad de un protocolo , 2001 .
[451] C. Grau,et al. Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer. , 2001, Acta oncologica.
[452] Ketan Verma,et al. Clinical evaluation of human placental extract (placentrex) in radiation-induced oral mucositis. , 2001, International journal of tissue reactions.
[453] K. Yuen,et al. Effects of clarithromycin on oral mucositis in bone marrow transplant recipients. , 2001, Haematologica.
[454] H. Worthington,et al. Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer). , 2000, The Cochrane database of systematic reviews.
[455] H. Minn,et al. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study. , 2000, International journal of radiation oncology, biology, physics.
[456] M. Serin,et al. Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies. , 2000, Oral oncology.
[457] G. Duncan,et al. Prophylaxis of radiation associated mucositis (RAM) in head and neck cancer, results of a double blind phase III trail evaluating the clinical efficacy of an antimicrobial lozenge utilizing a new validated mucositis scoring system , 2000 .
[458] Qing-min Guo. Prevention and Treatment of Oral Mucositis Caused By Radiotherapy in Patients With Nasopharyngeal Carcinoma , 2000 .
[459] H. Prentice,et al. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. , 1999, British journal of haematology.
[460] S. McCann,et al. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study , 1999, Bone Marrow Transplantation.
[461] M. Hayran,et al. Sucralfate in the prevention of radiation-induced oral mucositis. , 1999, Journal of clinical gastroenterology.
[462] E. Spasov,et al. Antifungal prophylaxis with low doses fluconazole in patients with hematological malignancies. , 1999, Folia medica.
[463] H. Minn,et al. Abstract of ASTRO scientific papers to be presented178 Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: A prospective randomized study , 1999 .
[464] L. Madero,et al. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia. , 1999, Haematologica.
[465] D. Weisdorf,et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation , 1998, Bone Marrow Transplantation.
[466] Y. Lei,et al. [The second phase clinical observation of anti-radiation effect by superoxide dismutase]. , 1998, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University.
[467] G. Calais,et al. Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. Results of the 94.01 randomized study from the french group of radiation oncology for head and neck cancer (Gortec) , 1998 .
[468] Stephen J. Sharp,et al. Meta-analysis regression , 1998 .
[469] P. Lambin,et al. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[470] J. Crowley,et al. Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study , 1997, Cancer Chemotherapy and Pharmacology.
[471] B. D. de Pauw. Practical modalities for prevention of fungal infections in cancer patients. , 1997, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.
[472] K. Reimer,et al. Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. , 1997, Dermatology.
[473] S. Wang,et al. Mouth care for nasopharyngeal cancer patients undergoing radiotherapy. , 1997, Oral oncology.
[474] E. Erkurt,et al. The use of recombinant human granulocyte colony-stimulating factor in combination with single or fractionated doses of ifosfamide and doxorubicin in patients with advanced soft tissue sarcoma. , 1996, Journal of chemotherapy.
[475] T. Feber. Management of mucositis in oral irradiation. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).
[476] M. Mehta,et al. 2047 Definition of AVM nidus for radiosurgery using segmentation tools , 1995 .
[477] K. Shin,et al. Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. , 1995, Cancer investigation.
[478] A. Priour. [Prevention of mucositis]. , 1995, Soins. Pediatrie, puericulture.
[479] R. Henriksson,et al. Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study. , 1995, Acta oncologica.
[480] A. Ibatici,et al. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation. , 1995, Haematologica.
[481] V. Ribrag,et al. [Treatment of mucositis with vitamin E during administration of neutropenic antineoplastic agents]. , 1994, Annales de medecine interne.
[482] A. Laplanche,et al. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. , 1994, European journal of cancer. Part B, Oral oncology.
[483] J. Raemaekers,et al. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study. , 1993, Leukemia & lymphoma.
[484] Jonathan Y. Ito,et al. Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group. , 1992, Chemotherapy.
[485] D. Hodson,et al. Management of oral mucosal dysplasia with beta-carotene retinoic acid: a pilot cross-over study. , 1991, Cancer detection and prevention.
[486] O. Hansen,et al. Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. A randomized, double-blind cross-over study. , 1990, Acta oncologica.
[487] K. Brammer. Management of fungal infection in neutropenic patients with fluconazole. , 1990, Haematology and blood transfusion.
[488] G. Samonis,et al. Prophylaxis of candidiasis in cancer patients. , 1990, Seminars in oncology.
[489] A. Lentnek,et al. Comparative evaluation of nystatin pastille and clotrimazole troche for the treatment of candidal stomatitis in immunocompromised patients. , 1990 .
[490] R. Finke. [Comparison of oral fluconazole and amphotericin B prophylaxis against fungal infections in the neutropenic phase of patients treated with antileukemic agents]. , 1990, Mycoses.
[491] A. Scherlacher,et al. [Radiotherapy of head-neck neoplasms: prevention of inflammation of the mucosa by sucralfate treatment]. , 1990, HNO.
[492] B. R. Rothwell,et al. Palliation of radiation-related mucositis. , 1990, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[493] W. Woods,et al. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. , 1989, Bone marrow transplantation.
[494] F. Meunier. Empirical antifungal therapy in febrile granulocytopenic patients , 1989 .
[495] I. P. Hunter,et al. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. , 1988, Clinical radiology.
[496] M. Schubert,et al. The use of benzydamine HCl for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study. , 1987, International journal of tissue reactions.
[497] L. G. Malcom,et al. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients. , 1987, Cancer investigation.
[498] H. Pedersen,et al. Oral ftorafur versus intravenous 5-fluorouracil. A comparative study in patients with colorectal cancer. , 1987, Acta oncologica.
[499] C. Bernasconi,et al. INFEZIONI MICOTICHE IN PAZIENTI AFFETTI DA LEUCEMIA ACUTa MIELOIDE VALUTAZIONE CLINICO-MICROBIOLOGICA DI UN PROTOCOLLO DI PROFILASSI ANTIMICOTICA , 1986 .
[500] J. Kim,et al. A clinical study of benzydamine for the treatment of radiotherapy-induced mucositis of the oropharynx. , 1985, International journal of tissue reactions.
[501] Park Se,et al. Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome. , 1985 .
[502] E. Bottone,et al. Clotrimazole treatment of oral candidiasis in patients with neoplastic disease. , 1984, The American journal of medicine.
[503] J. Klastersky,et al. Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients. , 1983, European journal of cancer & clinical oncology.
[504] T. Lister,et al. Oral anticandidal prophylaxis in patients undergoing chemotherapy for acut- leukemia. , 1977, Medical and pediatric oncology.